This post was contributed by a community member. The views expressed here are the author's own.

Neighbor News

Help Fund Gentler, More Effective Treatments for Kids With Cancer — VOLVO Doubles Donations Sept. 9–13! 💪

Every gift goes twice as far to support promising childhood cancer research at USC and Children's Hospital Los Angeles.

(Alex’s Lemonade Stand Foundation / Nathan’s Cancer Slayers)

Donate September 9–13 (Wed–Sun) to DOUBLE your GIFT to Nathan's Cancer Slayers, an Alex’s Lemonade Stand Foundation team!

For these five days only, VOLVO Cars will match donations dollar for dollar, up to $30,000 — DOUBLING your IMPACT for kids fighting cancer. 💪

CLICK HERE TO DONATE & DOUBLE YOUR IMPACT! 🏋️

Find out what's happening in Arlingtonfor free with the latest updates from Patch.

Nathan’s Cancer Slayers works in memory of Nathan Fleming, who graduated from Washington-Liberty High School in 2019 while undergoing chemotherapy and radiation. He passed away a week after his 18th birthday.

Nathan was one of a kind, a great soul, and wise beyond his years. Loving and kind, funny, smart, a little bit goofy, and always positive. He would have turned 25 on September 20.

Find out what's happening in Arlingtonfor free with the latest updates from Patch.

Nathan enjoying an afternoon fishing in south Georgia. Nathan’s joyful spirit inspires Nathan’s Cancer Slayers every day. 💛✨

Since 2020, Nathan’s team has raised more than $815,000 to fight childhood cancer and is now working toward an incredible milestone: $1 MILLION raised in Nathan’s memory.

Nathan’s team directly funds promising research at USC and Children’s Hospital Los Angeles (CHLA), where researchers are testing a gentle, yet powerful “multi-hit” approach combining a fasting-mimicking diet, high-dose IV vitamin C and doxycycline alongside chemotherapy.

Michele and Spencer Fleming with Dr. Valter Longo, world-renowned expert on fasting, longevity and cancer, and Nathan’s Cancer Slayers’ lead researcher at USC.

This gentler approach helps protect healthy cells and reduce toxic side effects and has already shown promising results in adult trials for some of the toughest cancers, including lung, pancreatic, colorectal, and triple-negative breast cancers. Our goal is to move this work toward pediatric clinical trials within 2 to 3 years.

Learn more about Dr. Valter Longo and Dr. JinSeok Park, our lead researcher at CHLA.

Please help us make these five days count! Every donation made Sept. 9–13 will go twice as far. 💪 Help Us March to $1 MILLION! ⚔️

With Gratitude,
Nathan’s Family ♥️

The views expressed in this post are the author's own. Want to post on Patch?